SkinBioTherapeutics PLC
15 Silk House
Park Green
Macclesfield
Cheshire
SK11 7QJ
United Kingdom
Tel: 0161-468-2760
Website: http://www.skinbiotherapeutics.com
About SkinBioTherapeutics PLC
SkinBioTherapeutics is a life science company focused on skin health. The Company’s proprietary platform technology, SkinBiotix™, is based upon discoveries made by CEO Dr. Catherine O’Neill and Professor Andrew McBain.YEAR FOUNDED:
2015
LEADERSHIP:
CEO: Catherine O’Neill
CFO: Doug Quinn
CLINICAL TRIAL:
Please click here for clinical trial information.
FOLLOW SKINBIO:
Tweets by SkinBioTherapeutics
10 articles about SkinBioTherapeutics PLC
-
UK life sciences company, SkinBioTherapeutics, announces end of year results following news of first commercial deal
11/26/2019
SkinBioTherapeutics has announced its full year results and released details of its strengthened board and management team following the appointment of Stuart Ashman CEO.
-
SkinBioTherapeutics announces deal for development of new cosmetic skincare ingredient based on pioneering skin microbiome research
11/26/2019
Agreement with speciality chemical company, Croda International, to design and manufacture a new active skincare ingredient based on SkinBiotix™ technology and investigate specific cosmetic ingredient applications to target.
-
SKINBIOTHERAPEUTICS PLC: Business Update and Board Changes
7/4/2019
SkinBioTherapeutics plc, a life sciences company focused on skin health, announces changes to its Board and executive team and provides a business update.
-
SkinBioTherapeutics shortlisted for Best Technology at European Mediscience Awards 2019
5/16/2019
UK skin health company, SkinBioTherapeutics, has been shortlisted for Best Technology at the European Mediscience Awards 2019 for its innovative SkinBiotix® technology which is developing skin health therapies derived from the skin microbiome.
-
BioSpace Movers and Shakers: April 26
4/26/2019
Companies strengthen leadership teams with C-suite and boards of directors appointments, with new hires at Sandoz, Mission Bio, SkinBio, Epic Sciences, and more. -
Stuart Ashman appointed to the board of SkinBioTherapeutics
4/23/2019
SkinBioTherapeutics has appointed Stuart Ashman as an executive director, effective from April 18th.. Stuart will succeed Professor Cath O’Neill as CEO after a period of transition, which will enable him to gain an understanding of the science based company which is focused on skin health
-
SkinBioTherapeutics plc: CEO Designate Appointment
3/29/2019
SkinBioTherapeutics plc (AIM: SBTX or the “Company”), a life sciences company focused on skin health, announces the appointment of Stuart Ashman as an Executive Director of the Company, subject to the completion of regulatory due diligence checks.
-
SkinBioTherapeutics on track for development of scientifically based skin microbiome treatments
2/15/2019
UK based SkinBioTherapeutics is developing a range of scientifically validated treatments derived from probiotic bacteria for use in cosmetics, infection control products and for the treatment of eczema
-
SkinBioTherapeutics PLC - Full Year Results
10/5/2017
-
SkinBioTherapeutics PLC, A Subsidiary Of Microbiome Specialist OptiBiotix, To Float On The UK AIM Market
3/27/2017